Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

21st-Jan-2013 12:20Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives final approvals for Oxacillin Injections

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials (ANDA 201539) and Oxacillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 201538). The products are ready for launch.

More Announcements on:

20th-May-2017 17:19Source: BSE

Aurobindo Pharm - Updates

16th-May-2017 13:31Source: NSE

Aurobindo Pharma Limited

16th-May-2017 12:24Source: BSE

Aurobindo Pharm - Updates

12th-May-2017 16:03Source: BSE

Aurobindo Pharm - Updates

28th-Apr-2017 16:25Source: BSE

Aurobindo Pharm - Updates on Acquisition

19th-Apr-2017 15:47Source: NSE

Aurobindo Pharma Limited

19th-Apr-2017 14:37Source: BSE

Aurobindo Pharm - Updates

19th-Apr-2017 14:25Source: NSE

Aurobindo Pharma Limited

1 2 3 4 5 Next >>
Board Meeting (Aurobindo Pharm)

Meeting Date

Remark

2017-05-29

Audited Results & Dividend

Sections
Follow us on
Available On